Skip to main content

The Patient Acceptable Symptom State in Female Urinary Incontinence.

Publication ,  Journal Article
Sanderson, DJ; Zavez, A; Meekins, AR; Eddib, A; Lee, TG; Barber, MD; Duecy, E
Published in: Female Pelvic Med Reconstr Surg
January 1, 2022

OBJECTIVE: The objective of this study is to characterize an acceptable health state, using the patient acceptable symptom state (PASS) question, in adult women with urinary incontinence. METHODS: This is a prospective multicenter cohort study determining PASS thresholds from condition-specific measures using an electronic research platform in English-speaking women seeking nonsurgical treatment of urinary incontinence between March 2019 and May 2020. Exclusions included pregnancy, isolated overactive bladder, and pelvic organ prolapse greater than stage II. The cohort was described and then grouped based on achievement of PASS. The PASS thresholds were determined using the 75th percentile and univariate regression methods. Multivariable regression modeling was used to understand the influence of covariates on PASS achievement. RESULTS: The study was completed by 100 (80%) of the 125 enrolled subjects. Of these, 45% (n = 45) achieved PASS after a median of 7 weeks of treatment (range, 6-13 weeks). The corresponding questionnaire score for PASS was estimated to be 6 for the Incontinence Severity Index, 3 for the Patient Global Impression of Severity and Improvement, 37.5 using the Urinary Distress Inventory 6, and 33.3 using the Incontinence Impact Questionnaire 7. Increasing age was independently associated with achieving PASS after adjusting for treatment adherence and outcomes scores (adjusted odds ratio, 1.05 [95% confidence interval, 1.01-1.10]; P = 0.02). CONCLUSIONS: PASS was achieved in 45% of women after conservative treatment of urinary incontinence. PASS offers a new perspective for analysis and interpretation of outcome measures used in pelvic floor disorders and can serve as a reference for future research and clinical care pathways.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Female Pelvic Med Reconstr Surg

DOI

EISSN

2154-4212

Publication Date

January 1, 2022

Volume

28

Issue

1

Start / End Page

33 / 39

Location

United States

Related Subject Headings

  • Urinary Incontinence
  • Surveys and Questionnaires
  • Prospective Studies
  • Pregnancy
  • Pelvic Organ Prolapse
  • Pelvic Floor Disorders
  • Humans
  • Female
  • Cohort Studies
  • 3215 Reproductive medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sanderson, D. J., Zavez, A., Meekins, A. R., Eddib, A., Lee, T. G., Barber, M. D., & Duecy, E. (2022). The Patient Acceptable Symptom State in Female Urinary Incontinence. Female Pelvic Med Reconstr Surg, 28(1), 33–39. https://doi.org/10.1097/SPV.0000000000001055
Sanderson, Derrick J., Alexis Zavez, A Rebecca Meekins, Abeer Eddib, Toy G. Lee, Matthew D. Barber, and Erin Duecy. “The Patient Acceptable Symptom State in Female Urinary Incontinence.Female Pelvic Med Reconstr Surg 28, no. 1 (January 1, 2022): 33–39. https://doi.org/10.1097/SPV.0000000000001055.
Sanderson DJ, Zavez A, Meekins AR, Eddib A, Lee TG, Barber MD, et al. The Patient Acceptable Symptom State in Female Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2022 Jan 1;28(1):33–9.
Sanderson, Derrick J., et al. “The Patient Acceptable Symptom State in Female Urinary Incontinence.Female Pelvic Med Reconstr Surg, vol. 28, no. 1, Jan. 2022, pp. 33–39. Pubmed, doi:10.1097/SPV.0000000000001055.
Sanderson DJ, Zavez A, Meekins AR, Eddib A, Lee TG, Barber MD, Duecy E. The Patient Acceptable Symptom State in Female Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2022 Jan 1;28(1):33–39.

Published In

Female Pelvic Med Reconstr Surg

DOI

EISSN

2154-4212

Publication Date

January 1, 2022

Volume

28

Issue

1

Start / End Page

33 / 39

Location

United States

Related Subject Headings

  • Urinary Incontinence
  • Surveys and Questionnaires
  • Prospective Studies
  • Pregnancy
  • Pelvic Organ Prolapse
  • Pelvic Floor Disorders
  • Humans
  • Female
  • Cohort Studies
  • 3215 Reproductive medicine